Revance Therapeutics Price to Book Ratio 2012-2020 | RVNC

Historical price to book ratio values for Revance Therapeutics (RVNC) over the last 10 years. The current price to book ratio for Revance Therapeutics as of December 03, 2020 is 4.32.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Revance Therapeutics Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2020-12-04 24.32 4.34
2020-09-30 25.14 $5.60 4.49
2020-06-30 24.42 $4.46 5.47
2020-03-31 14.80 $5.41 2.74
2019-12-31 16.23 $4.31 3.77
2019-09-30 13.00 $3.43 3.79
2019-06-30 12.97 $4.27 3.03
2019-03-31 15.76 $5.02 3.14
2018-12-31 20.13 $3.94 5.11
2018-09-30 24.85 $4.92 5.05
2018-06-30 27.45 $5.68 4.83
2018-03-31 30.80 $6.44 4.78
2017-12-31 35.75 $7.36 4.86
2017-09-30 27.55 $4.59 6.00
2017-06-30 26.40 $5.24 5.04
2017-03-31 20.80 $5.93 3.51
2016-12-31 20.70 $6.18 3.35
2016-09-30 16.21 $7.04 2.30
2016-06-30 13.60 $7.58 1.80
2016-03-31 17.46 $8.32 2.10
2015-12-31 34.16 $8.95 3.82
2015-09-30 29.76 $5.86 5.08
2015-06-30 31.98 $6.22 5.15
2015-03-31 20.73 $6.83 3.04
2014-12-31 16.94 $7.42 2.28
2014-09-30 19.33 $7.92 2.44
2014-06-30 34.00 $8.45 4.02
2014-03-31 31.50 $4.22 7.47
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.609B $0.000B
Revance is a Silicon Valley-based biotechnology company. The company is developing a portfolio of products for aesthetic medicine and underserved therapeutic specialties, including dermatology and neurology. Revance's science is based upon a proprietary TransMTS? peptide technology, which when combined with active drug molecules, may help address current unmet needs. Revance's initial focus is on developing daxibotulinumtoxinA, the company's highly purified botulinum toxin, for a broad spectrum of aesthetic and therapeutic indications, including facial wrinkles and muscle movement disorders. The company's lead drug candidate, DaxibotulinumtoxinA for Injection (RT002), is currently in development for the treatment of glabellar lines and cervical dystonia and has the potential to be the first long-acting neurotoxin. The company holds worldwide rights for all indications of RT002 injectable and RT001 topical and the pharmaceutical uses of the TransMTS technology platform.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $140.694B 10.03
Amgen (AMGN) United States $131.896B 13.79
CSL (CSLLY) Australia $100.576B 0.00
Gilead Sciences (GILD) United States $76.628B 10.19
Vertex Pharmaceuticals (VRTX) United States $58.951B 27.41
Moderna (MRNA) United States $56.587B 0.00
Regeneron Pharmaceuticals (REGN) United States $53.901B 19.12
Illumina (ILMN) United States $49.760B 68.44
Biogen (BIIB) United States $37.996B 6.75
Seagen (SGEN) United States $31.921B 84.31
BioNTech SE (BNTX) Germany $27.398B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.863B 10.70
Genmab (GMAB) Denmark $25.117B 29.70
Genmab (GNMSF) Denmark $23.856B 5.49
BeiGene (BGNE) Cayman Islands $20.611B 0.00
Exact Sciences (EXAS) United States $18.714B 0.00
Incyte (INCY) United States $18.017B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.183B 0.00
Bio-Rad Laboratories (BIO.B) United States $16.596B 62.94
Horizon Therapeutics Public (HZNP) Ireland $15.348B 21.94
Alnylam Pharmaceuticals (ALNY) United States $15.042B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.497B 96.22
ARGENX SE-ADR (ARGX) Netherlands $13.533B 0.00
Guardant Health (GH) United States $11.962B 0.00
Sarepta Therapeutics (SRPT) United States $11.835B 0.00
Bio-Techne Corp (TECH) United States $11.518B 73.66
Mirati Therapeutics (MRTX) United States $11.387B 0.00
QIAGEN (QGEN) Netherlands $10.873B 24.48
Repligen (RGEN) United States $9.840B 139.55
CRISPR Therapeutics AG (CRSP) Switzerland $9.294B 0.00
Ascendis Pharma (ASND) Denmark $8.987B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.701B 0.00
Galapagos (GLPG) Belgium $8.156B 0.00
Novavax (NVAX) United States $7.988B 0.00
Denali Therapeutics (DNLI) United States $7.497B 0.00
Ultragenyx Pharmaceutical (RARE) United States $7.202B 0.00
Acceleron Pharma (XLRN) United States $7.036B 0.00
Adaptive Biotechnologies (ADPT) United States $6.523B 0.00
Amicus Therapeutics (FOLD) United States $6.053B 0.00
Exelixis (EXEL) United States $5.997B 40.27
Blueprint Medicines (BPMC) United States $5.886B 19.49
SWEDISH ORP BIO (BIOVF) Sweden $5.829B 15.93
Halozyme Therapeutics (HALO) United States $5.497B 254.13
Fate Therapeutics (FATE) United States $5.281B 0.00
NeoGenomics (NEO) United States $5.247B 1575.17
Twist Bioscience (TWST) United States $5.196B 0.00
China Biologic Products (CBPO) China $4.677B 30.31
Reata Pharmaceuticals (RETA) United States $4.625B 0.00
Emergent Biosolutions (EBS) United States $4.343B 14.25
Insmed (INSM) United States $4.049B 0.00
Vir Biotechnology (VIR) United States $3.944B 0.00
Legend Biotech (LEGN) United States $3.935B 0.00
Arena Pharmaceuticals (ARNA) United States $3.820B 0.00
MorphoSys AG (MOR) Germany $3.718B 134.57
Eidos Therapeutics (EIDX) United States $3.468B 0.00
Beam Therapeutics (BEAM) United States $3.317B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.237B 0.00
Bluebird Bio (BLUE) United States $3.066B 0.00
Alkermes (ALKS) Ireland $2.995B 29.41
Global Blood Therapeutics (GBT) United States $2.767B 0.00
Zymeworks (ZYME) Canada $2.511B 0.00
Intellia Therapeutics (NTLA) United States $2.427B 0.00
Seres Therapeutics (MCRB) United States $2.293B 0.00
UniQure (QURE) Netherlands $2.255B 0.00
Viela Bio (VIE) United States $2.193B 0.00
PHARMA MAR SA (PHMMF) Spain $2.148B 0.00
I-Mab (IMAB) China $2.118B 0.00
Sorrento Therapeutics (SRNE) United States $2.043B 0.00
Alcobra (ARCT) United States $2.040B 0.00
Inovio Pharmaceuticals (INO) United States $2.028B 0.00
Intra-Cellular Therapies (ITCI) United States $2.015B 0.00
Editas Medicine (EDIT) United States $1.967B 0.00
Amarin (AMRN) Ireland $1.893B 0.00
Mesoblast (MESO) Australia $1.858B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.834B 0.00
Arcus Biosciences (RCUS) United States $1.764B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.688B 0.00
Scholar Rock Holding (SRRK) United States $1.680B 0.00
NGM Biopharmaceuticals (NGM) United States $1.646B 0.00
Mersana Therapeutics (MRSN) United States $1.612B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.607B 13.30
Precigen (PGEN) United States $1.586B 0.00
Zealand Pharma (ZEAL) Denmark $1.511B 0.00
Sangamo Therapeutics (SGMO) United States $1.412B 0.00
REGENXBIO (RGNX) United States $1.410B 0.00
Myriad Genetics (MYGN) United States $1.394B 0.00
Adverum Biotechnologies (ADVM) United States $1.367B 0.00
Epizyme (EPZM) United States $1.359B 0.00
Coherus BioSciences (CHRS) United States $1.358B 8.98
Ligand Pharmaceuticals (LGND) United States $1.342B 34.77
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Cytokineticsorporated (CYTK) United States $1.274B 0.00
Athenex (ATNX) United States $1.264B 0.00
Northwest Biotherapeutics (NWBO) United States $1.247B 0.00
Genetron Holdings (GTH) China $1.211B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.208B 0.00
Travere Therapeutics (TVTX) United States $1.194B 0.00
Heska (HSKA) United States $1.160B 0.00
Vericel (VCEL) United States $1.130B 0.00
Cellectis S.A (CLLS) France $1.129B 0.00
Codexis (CDXS) United States $1.119B 0.00
Alector (ALEC) United States $1.099B 0.00
Arvinas (ARVN) United States $1.024B 0.00
Pliant Therapeutics (PLRX) United States $1.011B 0.00
Castle Biosciences (CSTL) United States $1.002B 0.00
NantKwest (NK) United States $0.989B 0.00
Morphic Holding (MORF) United States $0.971B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.931B 0.00
Frequency Therapeutics (FREQ) United States $0.921B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.884B 0.00
Pharming Group (PHGUF) Netherlands $0.876B 20.00
Celldex Therapeutics (CLDX) United States $0.866B 0.00
Compugen (CGEN) Israel $0.859B 0.00
Protagonist Therapeutics (PTGX) United States $0.841B 0.00
Cardiff Oncology (CRDF) United States $0.788B 0.00
VBI Vaccines (VBIV) United States $0.784B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
MiMedx (MDXG) United States $0.742B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.738B 37.47
Kadmon Holdings (KDMN) United States $0.732B 0.00
Albireo Pharma (ALBO) United States $0.718B 0.00
Agenus (AGEN) United States $0.690B 0.00
AnaptysBio (ANAB) United States $0.676B 0.00
MannKind (MNKD) United States $0.670B 0.00
Five Prime Therapeutics (FPRX) United States $0.661B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.637B 0.00
Sutro Biopharma (STRO) United States $0.631B 0.00
Precision BioSciences (DTIL) United States $0.609B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.598B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.594B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.592B 0.00
Dynavax Technologies (DVAX) United States $0.578B 0.00
IVERIC Bio (ISEE) United States $0.575B 0.00
Geron (GERN) United States $0.556B 0.00
MeiraGTx Holdings (MGTX) United States $0.542B 0.00
Avid Bioservices (CDMO) United States $0.538B 0.00
Anika Therapeutics (ANIK) United States $0.527B 71.29
Merus (MRUS) Netherlands $0.524B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.517B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.511B 0.00
Forte Biosciences (FBRX) United States $0.500B 0.00
Cel-Sci (CVM) United States $0.478B 0.00
Spero Therapeutics (SPRO) United States $0.470B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.461B 0.00
Puma Biotechnology (PBYI) United States $0.455B 0.00
WAVE Life Sciences (WVE) Singapore $0.448B 0.00
Prothena (PRTA) Ireland $0.442B 0.00
Cue Biopharma (CUE) United States $0.434B 0.00
Clovis Oncology (CLVS) United States $0.430B 0.00
Amryt Pharma (AMYT) United Kingdom $0.429B 0.00
Kala Pharmaceuticals (KALA) United States $0.420B 0.00
UROGEN PHARMA (URGN) United States $0.418B 0.00
Innate Pharma S.A (IPHA) France $0.408B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.404B 0.00
AC Immune SA (ACIU) Switzerland $0.400B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.398B 0.00
Affimed (AFMD) Germany $0.397B 0.00
Starpharma Holdings (SPHRY) Australia $0.396B 0.00
BioDelivery Sciences (BDSI) United States $0.389B 18.33
Trevena (TRVN) United States $0.377B 0.00
Selecta Biosciences (SELB) United States $0.368B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.366B 0.00
Cellular Biomedicine (CBMG) United States $0.363B 0.00
Verastem (VSTM) United States $0.360B 0.00
XOMA (XOMA) United States $0.358B 0.00
Athersys (ATHX) United States $0.352B 0.00
Syros Pharmaceuticals (SYRS) United States $0.350B 0.00
ANI Pharmaceuticals (ANIP) United States $0.350B 8.90
CytomX Therapeutics (CTMX) United States $0.343B 0.00
Arbutus Biopharma (ABUS) United States $0.335B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.305B 0.00
ChromaDex (CDXC) United States $0.303B 0.00
Kamada (KMDA) Israel $0.301B 14.06
IBio (IBIO) United States $0.290B 0.00
PDL BioPharma (PDLI) United States $0.289B 0.00
NextCure (NXTC) United States $0.283B 0.00
CorMedix Inc (CRMD) United States $0.276B 0.00
Pluristem Therapeutics (PSTI) Israel $0.269B 0.00
DBV Technologies S.A (DBVT) France $0.267B 0.00
Fortress Biotech (FBIO) United States $0.262B 0.00
AquaBounty Technologies (AQB) United States $0.256B 0.00
HOOKIPA Pharma (HOOK) United States $0.240B 0.00
Aptinyx (APTX) United States $0.237B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.228B 0.00
TELA Bio (TELA) United States $0.219B 0.00
Nicox SA (NICXF) France $0.207B 0.00
GENFIT S.A (GNFT) France $0.203B 0.00
Aptevo Therapeutics (APVO) United States $0.198B 0.00
Eton Pharmaceuticals (ETON) United States $0.195B 0.00
ADMA Biologics Inc (ADMA) United States $0.188B 0.00
Bellus Health (BLU) Canada $0.186B 0.00
Cerecor (CERC) United States $0.186B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Strongbridge Biopharma (SBBP) United States $0.184B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.183B 0.00
Idera Pharmaceuticals (IDRA) United States $0.183B 0.00
Theratechnologies (THTX) Canada $0.182B 0.00
Checkpoint Therapeutics (CKPT) United States $0.174B 0.00
Dyadic (DYAI) United States $0.165B 0.00
SESEN BIO, INC (SESN) United States $0.163B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
VolitionRX (VNRX) United States $0.160B 0.00
Biofrontera AG (BFRA) Germany $0.158B 0.00
Abeona Therapeutics (ABEO) United States $0.154B 0.00
VTv Therapeutics (VTVT) United States $0.152B 0.00
Kindred Biosciences (KIN) United States $0.151B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.151B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.148B 0.00
Oncobiologics (OTLK) United States $0.148B 0.00
Cogent Biosciences (COGT) United States $0.138B 0.00
Celyad SA (CYAD) Belgium $0.130B 0.00
Applied Genetic Technologies (AGTC) United States $0.129B 0.00
Exicure (XCUR) United States $0.128B 0.00
TRACON Pharmaceuticals (TCON) United States $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Lumos Pharma (LUMO) United States $0.128B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.114B 0.00
Gritstone Oncology (GRTS) United States $0.112B 0.00
Aytu Bioscience (AYTU) United States $0.112B 0.00
Liquidia Technologies (LQDA) United States $0.111B 0.00
Curis (CRIS) United States $0.111B 0.00
Windtree Therapeutics (WINT) United States $0.109B 0.00
Orgenesis (ORGS) United States $0.106B 220.00
Palatin Technologies (PTN) United States $0.105B 0.00
Cocrystal Pharma (COCP) United States $0.105B 0.00
Enzo Biochem (ENZ) United States $0.104B 0.00
Cyclerion Therapeutics (CYCN) United States $0.104B 0.00
Clearside Biomedical (CLSD) United States $0.100B 0.00
Prometic Life Sciences (LMNL) Canada $0.099B 0.00
DiaMedica Therapeutics (DMAC) United States $0.096B 0.00
Novogen (KZIA) Australia $0.095B 0.00
AIT Therapeutics (XAIR) United States $0.094B 0.00
Cidara Therapeutics (CDTX) United States $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
Ecology Coatings (ABVC) United States $0.087B 0.00
Evogene (EVGN) Israel $0.087B 0.00
Synlogic (SYBX) United States $0.086B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.082B 0.00
Prima BioMed (IMMP) Australia $0.076B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.076B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Soligenix (SNGX) United States $0.069B 0.00
Stealth BioTherapeutics (MITO) United States $0.068B 32.63
Adocia (ADOCY) France $0.067B 0.00
MiRagen Therapeutics (MGEN) United States $0.065B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
Vascular Biogenics (VBLT) Israel $0.062B 0.00
Armata Pharmaceuticals (ARMP) United States $0.059B 0.00
Appili Therapeutics (APLIF) Canada $0.059B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.058B 0.00
AnPac Bio-Medical Science (ANPC) China $0.057B 0.00
Emmaus Life Sciences (EMMA) United States $0.056B 0.00
Organovo Holdings (ONVO) United States $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
CollPlant Holdings (CLGN) Israel $0.053B 0.00
Seelos Therapeutics (SEEL) United States $0.051B 0.00
Happiness Biotech Group (HAPP) China $0.048B 0.00
Pulmatrix (PULM) United States $0.047B 0.00
Vaccinex (VCNX) United States $0.047B 0.00
Edesa Biotech (EDSA) Canada $0.044B 0.00
ATyr Pharma (LIFE) United States $0.043B 0.00
Genetic Technologies (GENE) Australia $0.043B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.042B 0.00
Cleveland BioLabs (CBLI) United States $0.040B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
Acorda Therapeutics (ACOR) United States $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
BioCardia (BCDA) United States $0.030B 0.00
AEterna Zentaris (AEZS) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Celsion (CLSN) United States $0.022B 0.00
Spherix (AIKI) United States $0.021B 0.00
Prana Biotechnology (ATHE) Australia $0.021B 0.00
Advaxis (ADXS) United States $0.021B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.020B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
Invo BioScience (INVO) United States $0.016B 0.00
BioPharmX (TMBR) United States $0.013B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00